Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WEE1 | P30291 | 3/20 | 0.44 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | JAK3 | P52333 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 1/20 | 0.40 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.39 |
| ▸ | IGF1R | P08069 | 2/20 | 0.39 |
| ▸ | SRC | P12931 | 2/20 | 0.39 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962757 | 1.00 | WEE1 (0.44) | WEE1TNK2LCKJAK3BTK | |
| SCHEMBL30962665 | 1.00 | WEE1 (0.44) | WEE1TNK2LCKJAK3BTK | |
| SCHEMBL30962837 | 0.96 | TNK2 (0.41) | WEE1TNK2LCKJAK3BTK | |
| SCHEMBL30962800 | 0.96 | TNK2 (0.41) | WEE1TNK2LCKJAK3BTK | |
| SCHEMBL30962932 | 0.88 | LCK (0.40) | TNK2LCKIGF1RSRCALK | |
| SCHEMBL30962871 | 0.88 | LCK (0.40) | TNK2LCKIGF1RSRCALK | |
| SCHEMBL30962746 | 0.88 | LCK (0.41) | TNK2LCKJAK3BTKPTK2 | |
| SCHEMBL30962787 | 0.87 | WEE1 (0.51) | WEE1TNK2LCKJAK3PTK2 | |
| SCHEMBL27313554 | 0.87 | WEE1 (0.51) | WEE1TNK2LCKJAK3PTK2 | |
| SCHEMBL30962635 | 0.86 | WEE1 (0.46) | WEE1TNK2LCKJAK3PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |